Glomerulonephritis is a rapidly evolving area of nephrology with major advances in disease pathogenesis and therapeutic targets leading to changes in clinical practice.
Join us for this two-day event, a collaboration between RSM Nephrology and Kidney Research UK Glomerulonephritis Clinical Study Group (GN CSG). We will explore the latest advances in the treatment and pathogenesis of primary and multisystem glomerular diseases. Through interactive lectures, case-based sessions, and panel discussions, we'll delve into the evolving clinical landscape and what it means for patient care.
Who should attend?
This meeting is a collaboration between clinicians, scientists, and healthcare professionals with an interest in glomerular diseases.
By attending this meeting, you will:
Gain CPD points: Day 1 is worth 6 CPD points and Day 2 is worth 6 CPD points
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
We would like to thank our sponsors Alexion, argenx, AstraZeneca, Biogen, CSL Vifor, Dimerix, Hansa Biopharma, Otsuka Pharmaceutical, Purespring Therapeutics, Roche Products Ltd, Sobi, STADA Thornton & Ross, Vera Therapeutics and Vertex Pharmaceuticals for their financial support of this independent meeting.
This activity has also been supported by Alentis Therapeutics and Novartis in the form of an educational grant.
The companies listed have had no influence or input into the agenda, content or organisation of this meeting.
Dr Francesco Rainone, President, Nephrology Section, Royal Society of Medicine
Chairs: Professor Richard Coward, University of Bristol and Dr Melanie Chan, Imperial College London
Professor Moin Saleem, University of Bristol
Professor Daniel Gale, University College London
Dr Rebecca Preston, University of Manchester
Professor Megan Griffith, Imperial College London
Chairs: Dr Durga Kanigicherla, Manchester University NHS Foundation Trust and Dr Samira Bell, University of Dundee
Professor Pierre Ronco, Sorbonne Université, Paris
Dr Ruth Pepper, Royal Free Hospital
Professor Helen Lachmann, The National Amyloidosis Centre, University College London
Chairs: Dr Patrick Hamilton, Manchester University NHS Foundation Trust and Professor Kate Bramham, Kings College London
Professor Tobias Huber, University of Hamburg
Dr Lisa Willcocks, Addenbrooke's Hospital, Cambridge
Dr Laura Mariani, University of Michigan
Professor Smeeta Sinha, Northern Care Alliance, Salford
Chairs: Professor Liz Lightstone and Professor Alan Salama
Panellists: Smeeta Sinha, Hayley Wells, Lisa Willcocks, Daniel Gale, David Wheeler
Chairs: Professor Colin Geddes, NHS Greater Glasgow and Clyde and Dr Candice Roufosse, Imperial College London
Panellists: Laura Mariani, Tobias Huber, Pierre Ronco, Liz Lightstone
Dr Francesco Rainone, President, Nephrology Section, Royal Society of Medicine
Dr Francesco Rainone, President, Nephrology Section, Royal Society of Medicine
Chairs: Dr Rupert Beale, The Francis Crick Institute, London and Dr Wen Ding, University Hospitals Bristol and Weston Foundation Trust
Dr Katherine Bull, University of Oxford
Dr Rona Smith, University of Cambridge, and Professor Louise Oni, University College London
Dr Sally Johnson, The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Chairs: Dr Michael Robson, Guy’s and St Thomas’ NHS Foundation Trust and Professor Sian Griffin, Consultant Nephrologist and Clinical Trials lead, University Hospital of Wales in Cardiff
Professor David Jayne, University of Cambridge
Dr Edwin Wong, Newcastle upon Tyne Hospitals NHS Foundation Trust
Dr Silke Brix, Manchester University NHS Foundation Trust
Professor Liz Lightstone, Imperial College London
Chairs: Dr Richard Hull, St George’s University Hospitals NHS Trust, and Dr Nadia Sarween, Consultant Nephrologist, University Hospitals Birmingham
Patient Panel and discussion
Chairs: Dr Haresh Selvaskandan, University of Leicester, Dr Katie Wong, University College London
Professor Neil Sheerin, University of Newcastle
Dr Chee Kay Cheung, University of Hospitals of Leicester NHS Trust
Dr Steve McAdoo, Imperial College London
Chairs: Dr Rachel Jones, Addenbrooke's Hospital, Cambridge and Professor Ian Roberts, University of Oxford
Panellists: Silke Brix, Jonathan Barratt, Alan Salama, Neil Sheerin, Kate Bramham
Dr Francesco Rainone, President, Nephrology Section, Royal Society of Medicine
Dr Francesco Rainone, President, Nephrology Section, Royal Society of Medicine
Chairs: Professor Richard Coward, University of Bristol and Dr Melanie Chan, Imperial College London
Professor Moin Saleem, University of Bristol
Professor Daniel Gale, University College London
Dr Rebecca Preston, University of Manchester
Professor Megan Griffith, Imperial College London
Chairs: Dr Durga Kanigicherla, Manchester University NHS Foundation Trust and Dr Samira Bell, University of Dundee
Professor Pierre Ronco, Sorbonne Université, Paris
Dr Ruth Pepper, Royal Free Hospital
Professor Helen Lachmann, The National Amyloidosis Centre, University College London
Chairs: Dr Patrick Hamilton, Manchester University NHS Foundation Trust and Professor Kate Bramham, Kings College London
Professor Tobias Huber, University of Hamburg
Dr Lisa Willcocks, Addenbrooke's Hospital, Cambridge
Dr Laura Mariani, University of Michigan
Professor Smeeta Sinha, Northern Care Alliance, Salford
Chairs: Professor Liz Lightstone and Professor Alan Salama
Panellists: Smeeta Sinha, Hayley Wells, Lisa Willcocks, Daniel Gale, David Wheeler
Chairs: Professor Colin Geddes, NHS Greater Glasgow and Clyde and Dr Candice Roufosse, Imperial College London
Panellists: Laura Mariani, Tobias Huber, Pierre Ronco, Liz Lightstone
Dr Francesco Rainone, President, Nephrology Section, Royal Society of Medicine
Dr Francesco Rainone, President, Nephrology Section, Royal Society of Medicine
Chairs: Dr Rupert Beale, The Francis Crick Institute, London and Dr Wen Ding, University Hospitals Bristol and Weston Foundation Trust
Dr Katherine Bull, University of Oxford
Dr Rona Smith, University of Cambridge, and Professor Louise Oni, University College London
Dr Sally Johnson, The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Chairs: Dr Michael Robson, Guy’s and St Thomas’ NHS Foundation Trust and Professor Sian Griffin, Consultant Nephrologist and Clinical Trials lead, University Hospital of Wales in Cardiff
Professor David Jayne, University of Cambridge
Dr Edwin Wong, Newcastle upon Tyne Hospitals NHS Foundation Trust
Dr Silke Brix, Manchester University NHS Foundation Trust
Professor Liz Lightstone, Imperial College London
Chairs: Dr Richard Hull, St George’s University Hospitals NHS Trust, and Dr Nadia Sarween, Consultant Nephrologist, University Hospitals Birmingham
Patient panel and discussion
Chairs: Dr Haresh Selvaskandan, University of Leicester, and Dr Katie Wong, University College London
Professor Neil Sheerin, University of Newcastle
Dr Chee Kay Cheung, University of Hospitals of Leicester NHS Trust
Dr Steve McAdoo, Imperial College London
Chairs: Dr Rachel Jones, Addenbrooke's Hospital, Cambridge and Professor Ian Roberts, University of Oxford
Panellists: Silke Brix, Jonathan Barratt, Alan Salama, Neil Sheerin, Kate Bramham
Dr Francesco Rainone, President, Nephrology Section, Royal Society of Medicine
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registration for this event will close at 1:00 am on Wednesday, 21 January 2026. Late registrations will not be accepted.
The agenda is subject to change without notice.
If the event is recorded, only sessions with speaker permission will be made available afterward, and availability is not guaranteed.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine or the speakers' organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
